《Oracle Calls Force Majeure Already?》
Medtronic 分拆 MiniMed 是一项积极的战略举措，通过聚焦更高利润率的业务来支撑更快的盈利增长。
随着美敦力近期发起一项自愿换股要约，以分拆其糖尿病业务部门MiniMed，我一直在思考普通投资者会如何评估这类公司行为。
With Medtronic recently launching a voluntary exchange offer to spin off its diabetes business unit, MiniMed, I've been thinking about how ordinary investors might evaluate this type of corporate action.
在这种情况下，对于Mini Medtronic MiniMed，作为分拆过程的一部分，投资者可以获得7%的估值折让。
In this case, for Mini Medtronic MiniMed, there is a 7% valuation discount that you receive as an investor as part of the spin-off process.